Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Sander

Showing results (91-100 of 851) with videos related to

Pageof 86
Sort By:
Drug Safety|July 3, 2007
Negative effects of antiepileptic drugs on mood in patients with epilepsyMarco Mula, Josemir W Sander
Seminars in Neurology|June 1, 1996
Diabetic amyotrophy: current conceptsH W Sander, S Chokroverty
Developmental Medicine and Child Neurology|February 25, 2020
Transcranial magnetic stimulation as a biomarker of treatment response in children with epilepsySimona Balestrini, Josemir W Sander
Seizure|October 30, 2021
Effects of the COVID-19 pandemic on medication adherence: In the case of antiseizure medications, A scoping reviewSonia Menon, Josemir W Sander
European Neurology|October 16, 1999
Classification of the epilepsies: time for a change? A critical review of the International Classification of the Epilepsies and Epileptic Syndromes (ICEES) and its usefulness in clinical practice and epidemiological studies of epilepsyA D Everitt, J W Sander
Annals of Neurology|May 6, 2003
Valporic acid and prion proteinsJosemir W Sander, John S Duncan
Current Opinion in Neurology|November 23, 2021
Learning from the comorbidities of epilepsyNathan A Shlobin, Josemir W Sander
Current Neurology and Neuroscience Reports|May 16, 2019
The Use of Caffeine by People with Epilepsy: the Myths and the EvidencePrisca R Bauer, Josemir W Sander
Epilepsia|March 10, 2022
The need for a pragmatic seizure classification in clinical trialsNathan A Shlobin, Josemir W Sander
Lancet (London, England)|May 20, 1995
Lamotrigine versus carbamazepine in epilepsyM F O'Donoghue, J W Sander
Pageof 86

Showing results (91-100 of 851) with videos related to

Sort By:
Pageof 86
Drug Safety|July 3, 2007
Negative effects of antiepileptic drugs on mood in patients with epilepsyMarco Mula, Josemir W Sander
Seminars in Neurology|June 1, 1996
Diabetic amyotrophy: current conceptsH W Sander, S Chokroverty
Developmental Medicine and Child Neurology|February 25, 2020
Transcranial magnetic stimulation as a biomarker of treatment response in children with epilepsySimona Balestrini, Josemir W Sander
Seizure|October 30, 2021
Effects of the COVID-19 pandemic on medication adherence: In the case of antiseizure medications, A scoping reviewSonia Menon, Josemir W Sander
European Neurology|October 16, 1999
Classification of the epilepsies: time for a change? A critical review of the International Classification of the Epilepsies and Epileptic Syndromes (ICEES) and its usefulness in clinical practice and epidemiological studies of epilepsyA D Everitt, J W Sander
Annals of Neurology|May 6, 2003
Valporic acid and prion proteinsJosemir W Sander, John S Duncan
Current Opinion in Neurology|November 23, 2021
Learning from the comorbidities of epilepsyNathan A Shlobin, Josemir W Sander
Current Neurology and Neuroscience Reports|May 16, 2019
The Use of Caffeine by People with Epilepsy: the Myths and the EvidencePrisca R Bauer, Josemir W Sander
Epilepsia|March 10, 2022
The need for a pragmatic seizure classification in clinical trialsNathan A Shlobin, Josemir W Sander
Lancet (London, England)|May 20, 1995
Lamotrigine versus carbamazepine in epilepsyM F O'Donoghue, J W Sander
Pageof 86